CochLear Change in Accounts Receivable 2023-2024 | CHEOY
CochLear annual/quarterly change in accounts receivable history and growth rate from 2023 to 2024. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
- CochLear change in accounts receivable for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
- CochLear change in accounts receivable for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
- CochLear annual change in accounts receivable for 2024 was $-0.035B, a 41.33% decline from 2023.
- CochLear annual change in accounts receivable for 2023 was $-0.06B, a 58.21% increase from 2022.
- CochLear annual change in accounts receivable for 2022 was $-0.038B, a 0% decline from 2021.
| CochLear Annual Change in Accounts Receivable (Millions of US $) |
|
|---|---|
| 2024 | $-35 |
| 2023 | $-60 |
| 2022 | $-38 |
| 2021 | $N/A |
| 2020 | $N/A |
| 2019 | $N/A |
| 2018 | $N/A |
| 2017 | $N/A |
| 2016 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.281B | $1.488B |
| Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.129B | 26.36 |
| CVS Health (CVS) | United States | $80.640B | 10.03 |
| Elevance Health (ELV) | United States | $63.834B | 8.59 |
| Cencora (COR) | United States | $53.960B | 17.97 |
| DiDi Global (DIDIY) | China | $27.015B | 28.70 |
| Labcorp Holdings (LH) | United States | $21.603B | 17.17 |
| Natera (NTRA) | United States | $19.264B | 0.00 |
| BioMerieux (BMXMF) | France | $17.067B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.705B | 0.00 |
| ICON (ICLR) | Ireland | $12.747B | 12.27 |
| Solventum (SOLV) | United States | $12.448B | 12.87 |
| Medpace Holdings (MEDP) | United States | $12.046B | 31.88 |
| Viatris (VTRS) | United States | $11.021B | 3.90 |
| Revvity (RVTY) | United States | $10.036B | 17.68 |
| Sonic Healthcare (SKHHY) | Australia | $8.936B | 0.00 |
| HealthEquity (HQY) | United States | $7.942B | 34.79 |
| Avantor (AVTR) | United States | $7.758B | 11.38 |
| Charles River Laboratories (CRL) | United States | $7.371B | 13.98 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.273B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.885B | 32.86 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| BrightSpring Health Services (BTSG) | United States | $3.624B | 27.65 |
| Sotera Health (SHC) | United States | $3.185B | 18.10 |
| GeneDx Holdings (WGS) | United States | $3.023B | 69.70 |
| Surgery Partners (SGRY) | United States | $2.977B | 37.45 |
| Alignment Healthcare (ALHC) | United States | $2.745B | 0.00 |
| Concentras Parent (CON) | United States | $2.589B | 16.42 |
| Organon (OGN) | United States | $2.368B | 2.58 |
| Progyny (PGNY) | United States | $1.977B | 41.93 |
| Premier (PINC) | United States | $1.848B | 14.02 |
| PACS (PACS) | United States | $1.690B | 0.00 |
| Ardent Health (ARDT) | United States | $1.641B | 6.34 |
| Pediatrix Medical (MD) | United States | $1.261B | 8.42 |
| GoodRx Holdings (GDRX) | United States | $1.239B | 20.41 |
| Teladoc Health (TDOC) | United States | $1.228B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.040B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.656B | 225.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.648B | 8.02 |
| CareDx (CDNA) | United States | $0.642B | 11.83 |
| Embecta (EMBC) | United States | $0.605B | 4.08 |
| Performant Healthcare (PHLT) | United States | $0.597B | 0.00 |
| Omada Health (OMDA) | $0.501B | 0.00 | |
| Nutex Health (NUTX) | United States | $0.496B | 7.50 |
| So-Young (SY) | China | $0.490B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 10.48 |
| Sonida Senior Living (SNDA) | United States | $0.458B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.441B | 0.00 |
| SBC Medicals (SBC) | United States | $0.438B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.414B | 0.00 |
| Enhabit (EHAB) | United States | $0.395B | 26.00 |
| Oncology Institute (TOI) | United States | $0.371B | 0.00 |
| Agilon Health (AGL) | United States | $0.363B | 0.00 |
| LifeMD (LFMD) | United States | $0.313B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.142B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.098B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.095B | 0.00 |
| Biodesix (BDSX) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| KindlyMD (NAKA) | United States | $0.057B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| ModivCare (MODV) | United States | $0.033B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |